Bath & Body Works, Inc. $BBWI Shares Purchased by Vaughan Nelson Investment Management L.P.

Vaughan Nelson Investment Management L.P. boosted its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 33.8% during the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 2,852,040 shares of the company’s stock after purchasing an additional 719,795 shares during the period. Vaughan Nelson Investment Management L.P.’s holdings in Bath & Body Works were worth $53,248,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently bought and sold shares of BBWI. Royal Bank of Canada boosted its stake in shares of Bath & Body Works by 92.8% during the first quarter. Royal Bank of Canada now owns 59,877 shares of the company’s stock worth $1,815,000 after buying an additional 28,815 shares during the period. Goldman Sachs Group Inc. increased its position in Bath & Body Works by 15.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 645,970 shares of the company’s stock valued at $19,586,000 after acquiring an additional 87,529 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in Bath & Body Works by 7.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 562,757 shares of the company’s stock valued at $17,063,000 after acquiring an additional 36,684 shares during the period. Intech Investment Management LLC purchased a new stake in Bath & Body Works during the 1st quarter valued at approximately $1,155,000. Finally, Geneos Wealth Management Inc. raised its stake in Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after acquiring an additional 801 shares during the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.

Bath & Body Works Stock Performance

BBWI opened at $20.60 on Monday. The business’s fifty day moving average is $18.83 and its two-hundred day moving average is $20.20. The company has a market cap of $4.15 billion, a price-to-earnings ratio of 5.79, a PEG ratio of 2.04 and a beta of 1.42. Bath & Body Works, Inc. has a one year low of $14.27 and a one year high of $33.96.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.03. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The company had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.36 billion. During the same quarter in the prior year, the company earned $0.49 earnings per share. Bath & Body Works’s revenue was down 3.2% compared to the same quarter last year. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, analysts predict that Bath & Body Works, Inc. will post 2.62 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 19th. Investors of record on Friday, June 5th were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 3.9%. The ex-dividend date of this dividend was Friday, June 5th. Bath & Body Works’s dividend payout ratio is presently 22.47%.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the company. Wells Fargo & Company decreased their price objective on Bath & Body Works from $29.00 to $25.00 and set an “overweight” rating for the company in a research report on Thursday, May 28th. Raymond James Financial reissued a “market perform” rating on shares of Bath & Body Works in a report on Wednesday, May 27th. Weiss Ratings cut Bath & Body Works from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Tuesday, June 2nd. Deutsche Bank Aktiengesellschaft increased their price target on Bath & Body Works from $21.00 to $22.00 and gave the stock a “hold” rating in a report on Tuesday, March 3rd. Finally, Barclays dropped their price objective on shares of Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating on the stock in a research note on Thursday, May 28th. Three equities research analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Bath & Body Works has a consensus rating of “Hold” and a consensus price target of $21.93.

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.